The following is from The Vaccine Reaction. On Feb. 29, 2024, the U.S. Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices (ACIP) presented a preliminary analysis that showed that 23 adults over the age of 65 […]
CDC Preliminary Analysis: RSV vaccines for seniors linked to Guillain-Barré Syndrome Read More »
The following is from Fierce Pharma. GSK resolved a group of claims in California over heartburn medication Zantac. But the company is hardly out of the woods in the wide-ranging litigation. The pharma giant did not reveal terms of its settlements, calling
GlaxoSmithKline settles lawsuits claiming Zantac caused cancer Read More »
The following is from MedPage Today. The CDC’s advisors on Wednesday recommended the newly approved respiratory syncytial virus (RSV) vaccines for older adults, but opted not to give their strongest endorsement. In a series of two votes, the Advisory Committee
(READ) CDC stops short of full endorsement on RSV vaccine for older adults Read More »
